
Uncovering Potential: Zevra Therapeutics's Earnings Preview
Zevra Therapeutics (NASDAQ:ZVRA) is gearing up to announce its quarterly earnings on Monday, 2026-03-09. Here's a quick overview of what investors should know before the release.Analysts are estimating that Zevra Therapeutics will report an earnings per share (EPS) of $0.05.Anticipation surrounds Zevra Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.New investors should understand that while earnings performance is important, market reactions are often driven by guidance.Past Earnings PerformanceIn the previous earnings release, the company beat EPS by $0.02, leading to a 9.73% drop in the share price the following trading session.Here's a look at Zevra Therapeutics's past performance and the resulting price change:QuarterQ3 2025Q2 2025Q1 2025Q4 2024EPS Estimate-0.031.40-0.19-0.40EPS Actual-0.011.24-0.06-0.67Price Change %-9.73-19.813.43-1.86Stock PerformanceShares of Zevra Therapeutics were trading at $8.79 as of March 05. Over the last 52-week period, shares are up 8.0%. ...Full story available on Benzinga.com








